Welcome to our dedicated page for Quanex Building Products SEC filings (Ticker: NX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quanex Building Products's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quanex Building Products's regulatory disclosures and financial reporting.
Quanex Building Products Corporation is holding its annual meeting of stockholders on February 26, 2026 at its Houston headquarters. Holders of common stock as of January 7, 2026, when 45,938,400 shares were outstanding, may vote in person or by proxy.
Stockholders will vote on three key items: electing eight directors for one-year terms, an advisory "Say-on-Pay" vote on named executive officer compensation, and ratifying KPMG LLP as independent auditor for fiscal 2026 after replacing Grant Thornton LLP. The proxy also explains executive and director pay, incentive plan outcomes, and governance practices, noting 2025 incentive payouts below target after market headwinds despite successful integration of the Tyman acquisition and record safety performance.
Quanex Building Products Corporation reported that its audit committee dismissed Grant Thornton LLP as its independent registered public accounting firm and appointed KPMG LLP for the fiscal year ending October 31, 2026. Grant Thornton’s audit reports on the company’s 2024 and 2025 financial statements were clean, with no adverse or qualified opinions and no disagreements on accounting, disclosure, or audit scope. However, Grant Thornton issued adverse opinions on internal control over financial reporting for both years because of a material weakness in the design and operation of controls over preparing and reviewing the statement of cash flows, first identified in the fourth quarter of 2024 and still present as of this report. The company has authorized Grant Thornton to fully cooperate with KPMG and has filed Grant Thornton’s confirmation letter as an exhibit.
Quanex Building Products Corporation reported a governance update involving an external board observer. On January 6, 2026, Teleios Global Opportunities Master Fund notified the company that its designated observer to Quanex’s board of directors would resign, effective January 8, 2026. Following this resignation, Teleios will no longer hold any observer right with respect to the company’s board. This change affects only an observer role and does not describe any changes to the company’s directors or executive officers.
Quanex Building Products Corp. reported insider transactions involving Teleios-related entities that are listed as directors and more-than-10% owners with board representation. On December 16, 2025, the reporting persons executed transactions in 80,515 shares of common stock at a weighted average price of $16.5061 per share, described as occurring within a range of $16.49 to $16.52. On December 17, 2025, they transacted in an additional 119,485 shares at a weighted average price of $15.9387 per share, within a range of $15.65 to $16.43.
After these transactions, the reporting persons are shown as beneficially owning 4,421,879 shares of Quanex common stock indirectly through Teleios Global Opportunities Master Fund, Ltd. The filing states that Teleios Capital Partners GmbH, as investment manager, and its managing officer Igor Kuzniar may be deemed beneficial owners through their roles, while each disclaims beneficial ownership beyond their pecuniary interest.
Quanex Building Products Corporation reported significantly higher scale but a sharp swing to loss for the year ended October 31, 2025. Net sales rose 44% to $1,837,641, driven mainly by the August 2024 acquisition of U.K.-based Tyman plc, which added substantial hardware and extrusion revenue across global markets.
Profitability deteriorated as cost of sales and operating expenses increased and Quanex recorded a $302,284 goodwill impairment tied to its resegmented reporting units. The company moved from net income of $33,059 in 2024 to a net loss of $250,806, while interest expense nearly tripled due to higher borrowings for the Tyman deal.
Quanex now operates three segments—Hardware Solutions, Extruded Solutions and Custom Solutions—with meaningful Tyman contributions but lower operating margins, especially in Hardware and Custom Solutions. The company continues to face a material weakness in internal control over financial reporting related to its cash flow statement, and is executing a remediation plan while managing industry headwinds in housing, raw material costs and tariffs.
Quanex Building Products Corporation filed a current report announcing that it has released a new press release related to its results of operations and financial condition. The company states that this press release, dated December 11, 2025, is attached as an exhibit and incorporated by reference, indicating that key details about recent performance are contained in that separate document. Quanex’s common stock trades on the New York Stock Exchange under the symbol NX.
Quanex Building Products (NX) insider activity shows routine equity compensation and tax withholding. The company’s Senior Vice President, CFO & Treasurer reported receiving 16,600 shares of common stock on 12/04/2025 at a price of $0, reflecting a stock grant. On 12/07/2025, 2,070 shares were disposed of at $13.85 per share, with the filing explaining that these shares were sold to cover taxes due on vesting performance-based awards originally granted on December 7, 2022. After these transactions, the executive beneficially owns 88,827 shares directly.
Quanex Building Products director reports new deferred compensation units. On 12/04/2025, the reporting person, a director of Quanex Building Products Corp (NX), acquired 1,738.65 phantom stock units under the company’s Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of common stock, but distributions from the plan are made in cash at a time chosen by the director or upon death, disability, or termination of board service.
After this transaction, the director beneficially owned 20,473.582 phantom stock units held directly, which includes 104.816 units that were credited automatically through dividend reinvestment.
Quanex Building Products director reports additional deferred compensation units
A director of Quanex Building Products Corp. reported a new grant of 1,738.65 phantom stock units on December 4, 2025 under the company’s Deferred Compensation Plan. Each phantom stock unit is economically equivalent to one share of Quanex common stock, but is settled in cash rather than actual shares, generally beginning on a specified date chosen by the director or upon death, disability, or when board service ends.
After this transaction, the director beneficially holds 5,430.387 phantom stock units, including 20.6530 units that were added automatically through dividend reinvestment. The phantom units in this filing are reported as derivative securities with a reference price of $13.66 per unit.
Quanex Building Products Corp. director reports new deferred stock units. A Form 4 filing shows that on 12/04/2025 a director received 1,146.37 phantom stock units under the company’s Deferred Compensation Plan as a result of deferring director compensation.
Each phantom stock unit is the economic equivalent of one share of Quanex common stock and is priced at $13.66 in the transaction table. These units are recorded as a derivative security held directly by the reporting person. Distributions from the plan are made in cash, beginning on a date the participant selects or upon death, disability, or termination of service as a director.